NEPHSTAR®ULTRASENSITIVECRPKIT - COFEPRIS Registration 699R2020 SSA
Access comprehensive regulatory information for NEPHSTAR®ULTRASENSITIVECRPKIT (NEPHSTAR®ULTRASENSITIVECRPKIT) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 699R2020 SSA and manufactured by KABLA COMERCIAL, S.A. DEC.V.. The device was registered on June 16, 2020.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
PARALADETERMINACIÓNCUANTITATIVADELADETECCIÓNULTRASENSIBLEDELAPROTEÍNACREACTIVA(USCRP)HUMANAENSUEROCOMOAYUDAENELDIAGNÓSTICOYTRATAMIENTODEESTADOS INFLAMATORIOS, INFECCIÓNBACTERIANA Y ENFERMEDADES CARDIACAS.PARA USO EXCLUSIVO DE LABORATORIOSCLÍNICOS O DE GABINETES.
FOR THE QUANTITATIVE DETERMINATION OF THE ULTRASENSITIVE DETECTION OF HUMAN ACCREACTIVE PROTEIN (USCRP) IN SERUM AS AN AID IN THE DIAGNOSIS AND TREATMENT OF INFLAMMATORY STATES, BACTERIAL INFECTION AND HEART DISEASE. FOR USE ONLY IN CLINICAL LABORATORIES OR CABINETS.